Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Fake HIV Medications
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Fake Adderall
    • Poisonous cough syrup
    • Counterfeit Pill Crisis
  • Patients
    • Learn about Counterfeits and to Save Money Safely
    • The Drug Importation Debate
    • Drug Counterfeiters Get Light Sentences
    • Real Victims of Counterfeit Drugs
    • Talk to Your Family
    • HIV/HEPC Patients
    • Mexican Pharmacies
  • Professionals
    • Pharmacists
    • Doctors
    • Law Enforcement
    • Prosecution Document Library
    • Research On Drug Safety
  • Policy
    • Publications
    • Pharmaceutical Border Security
    • Drug Importation
    • PBM under-reimbursement
    • Illegal Pill Presses
    • Affordability Boards (PDABs)
    • Alternative funding programs (AFPs)
    • Pharmacy-to-pharmacy marketplaces
    • FOIA-ed Materials
    • Events, briefings, and op-eds
  • About Us
    • Join Our Mailing List
    • Members
    • PSM Leadership
    • Press Releases
    • Contact Us
Document Tags: 2:22-cr-00049-RSM, judgment, PDL Avanish Kumar Jha, PDL Cyendiv, PDL extradition, PDL India, PDL Jardiance, PDL Keytruda, PDL oncology drugs, PDL Xovoltib
Return to library

United States District Court
Western District of Washington

USA v Avanish Kumar Jha

Judgment

Filed July 2025

Read the document.

A-Jha-Judgment
© 2003-2023 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top